RGT 0.00% 30.0¢ argent biopharma limited

Ann: EU Medical Cannabis License Granted with Strategic Agreement, page-119

  1. 972 Posts.
    lightbulb Created with Sketch. 107
    You would think somebody died around here,we have just been through May and it sure done a number on holders and plenty of companies,go back and read march quarterly,big difference a month makes.

    The first commercial API extractions are expected to be produced in Q3 CY2017, once Good Manufacturing Practice (GMP) certification has been received from the Agency for Medicinal Products and Medical Devices of the Republic of Slovenia (JAZMP). The Facility will produce high margin API Cannabinoid extract for use in medicinal products, including in MXC’s own clinical studies and trials in Europe and Australia.

    The Facility represents a significant commercial advantage for MGC Pharmaceuticals as it will become one of only a few GMP certified API extraction facilities in Europe. The Company expects to receive GMP certification for the Facility in the June quarter.
 
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
(20min delay)
Last
30.0¢
Change
0.000(0.00%)
Mkt cap ! $13.58M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 2500 26.0¢
 

Sellers (Offers)

Price($) Vol. No.
30.0¢ 3022 4
View Market Depth
Last trade - 16.12pm 28/06/2024 (20 minute delay) ?
RGT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.